Literature DB >> 21880988

The conserved scavenger receptor cysteine-rich superfamily in therapy and diagnosis.

Vanesa Gabriela Martínez1, Søren Kragh Moestrup, Uffe Holmskov, Jan Mollenhauer, Francisco Lozano.   

Abstract

The scavenger receptor cysteine-rich (SRCR) superfamily of soluble or membrane-bound protein receptors is characterized by the presence of one or several repeats of an ancient and highly conserved protein module, the SRCR domain. This superfamily (SRCR-SF) has been in constant and progressive expansion, now up to more than 30 members. The study of these members is attracting growing interest, which parallels that in innate immunity. No unifying function has been described to date for the SRCR domains, this being the result of the limited knowledge still available on the physiology of most members of the SRCR-SF, but also of the sequence versatility of the SRCR domains. Indeed, involvement of SRCR-SF members in quite different functions, such as pathogen recognition, modulation of the immune response, epithelial homeostasis, stem cell biology, and tumor development, have all been described. This has brought to us new information, unveiling the possibility that targeting or supplementing SRCR-SF proteins could result in diagnostic and/or therapeutic benefit for a number of physiologic and pathologic states. Recent research has provided structural and functional insight into these proteins, facilitating the development of means to modulate the activity of SRCR-SF members. Indeed, some of these approaches are already in use, paving the way for a more comprehensive use of SRCR-SF members in the clinic. The present review will illustrate some available evidence on the potential of well known and new members of the SRCR-SF in this regard.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21880988     DOI: 10.1124/pr.111.004523

Source DB:  PubMed          Journal:  Pharmacol Rev        ISSN: 0031-6997            Impact factor:   25.468


  67 in total

1.  Complement Inhibition Attenuates Early Erythrolysis in the Hematoma and Brain Injury in Aged Rats.

Authors:  Ming Wang; Ya Hua; Richard F Keep; Shu Wan; Nemanja Novakovic; Guohua Xi
Journal:  Stroke       Date:  2019-06-10       Impact factor: 7.914

2.  Structural characterization of the third scavenger receptor cysteine-rich domain of murine neurotrypsin.

Authors:  Anselmo Canciani; Gianluca Catucci; Federico Forneris
Journal:  Protein Sci       Date:  2019-03-06       Impact factor: 6.725

3.  CD163 binding to haptoglobin-hemoglobin complexes involves a dual-point electrostatic receptor-ligand pairing.

Authors:  Marianne Jensby Nielsen; Christian Brix Folsted Andersen; Søren Kragh Moestrup
Journal:  J Biol Chem       Date:  2013-05-13       Impact factor: 5.157

Review 4.  The long elusive IgM Fc receptor, FcμR.

Authors:  Hiromi Kubagawa; Satoshi Oka; Yoshiki Kubagawa; Ikuko Torii; Eiji Takayama; Dong-Won Kang; Dewitt Jones; Naonori Nishida; Toshio Miyawaki; Luigi F Bertoli; Sheila K Sanders; Kazuhito Honjo
Journal:  J Clin Immunol       Date:  2014-05-03       Impact factor: 8.317

5.  Protective Effects of Human and Mouse Soluble Scavenger-Like CD6 Lymphocyte Receptor in a Lethal Model of Polymicrobial Sepsis.

Authors:  Mario Martínez-Florensa; Marta Consuegra-Fernández; Fernando Aranda; Noelia Armiger-Borràs; Marianna Di Scala; Esther Carrasco; Jerónimo Pachón; Jordi Vila; Gloria González-Aseguinolaza; Francisco Lozano
Journal:  Antimicrob Agents Chemother       Date:  2016-12-27       Impact factor: 5.191

6.  Retinal pigment epithelium and microglia express the CD5 antigen-like protein, a novel autoantigen in age-related macular degeneration.

Authors:  Alessandro Iannaccone; T J Hollingsworth; Diwa Koirala; David D New; Nataliya I Lenchik; Sarka Beranova-Giorgianni; Ivan C Gerling; Marko Z Radic; Francesco Giorgianni
Journal:  Exp Eye Res       Date:  2016-12-15       Impact factor: 3.467

7.  Early Versus Late Diagnosis of Complement Factor I Deficiency: Clinical Consequences Illustrated in Two Families with Novel Homozygous CFI Mutations.

Authors:  Clara Franco-Jarava; Elena Álvarez de la Campa; Xavier Solanich; Francisco Morandeira-Rego; Virgínia Mas-Bosch; Marina García-Prat; Xavier de la Cruz; Andrea Martín-Nalda; Pere Soler-Palacín; Manuel Hernández-González; Roger Colobran
Journal:  J Clin Immunol       Date:  2017-09-23       Impact factor: 8.317

Review 8.  CD163 and inflammation: biological, diagnostic, and therapeutic aspects.

Authors:  Anders Etzerodt; Søren K Moestrup
Journal:  Antioxid Redox Signal       Date:  2012-10-19       Impact factor: 8.401

Review 9.  AIM associated with the IgM pentamer: attackers on stand-by at aircraft carrier.

Authors:  Toru Miyazaki; Tomoko Yamazaki; Ryoichi Sugisawa; M Eric Gershwin; Satoko Arai
Journal:  Cell Mol Immunol       Date:  2018-01-29       Impact factor: 11.530

10.  Human-Specific Mutations and Positively Selected Sites in MARCO Confer Functional Changes.

Authors:  Kyle E Novakowski; Nicholas V L Yap; Charles Yin; Kaori Sakamoto; Bryan Heit; G Brian Golding; Dawn M E Bowdish
Journal:  Mol Biol Evol       Date:  2018-02-01       Impact factor: 16.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.